Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

The Tobias and Lechleiter families donated $20 million to establish the Institute for Clinical Innovation at IU Health, the ...

The stock market experienced quite a bit of volatility during President Donald Trump's first 100 days in office.

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

Real-time index price for S&P 500 Real Estate [Sector] (SRRE), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

INDIANAPOLIS — Indianapolis-based pharmaceutical giant Eli Lilly and Company will invest up to $250 million as part of an expanded partnership with Purdue University announced Friday, May 9. The ...

INDIANAPOLIS — Over the next eight years, Eli Lilly and Company and Purdue University will continue their partnership. According to an announcement on Friday morning, Lilly is expected to invest ...

INDIANAPOLIS and WEST LAFAYETTE, May 9, 2025 — Eli Lilly and Company (NYSE: LLY) and Purdue University announced Friday (May 9) a significant expansion of their long-standing alliance, with Lilly’s ...

S&P Global, a financial-data firm, expects sales of Lilly’s obesity drugs to overtake Novo’s by 2027 (see chart 1). PREMIUM Eli-Lilly-looks-set-to-steal-Novo-Nordisk-s-weight Investors are ...

Despite beating on its earnings Thursday, pharma giant Eli Lilly (LLY) suffered a nearly 12% loss in its stock, losing more than $90 billion in market cap in a single day. "We think the market ...

Unlimited access to C&EN’s daily news coverage on cen.acs.org Weekly delivery of the C ... Also backing the series A: Eli Lilly and Company, which recently chose Haya as a partner for a $1 ...

Subscribe here to receive future editions. Despite last week's investor jitters, Eli Lilly is far from losing its strong grip on the booming weight loss market. As part of the move, Caremark ...